SIM
DNTH icon

Spark Investment Management’s Dianthus Therapeutics DNTH Stock Holding History

Spark Investment Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,550
Closed -$408K – 603
2019
Q1 		$408K Sell
1,550
-94
-6% -$16.2K 0.02% 421
2018
Q4 		$149K Buy
+1,644
New +$224K 0.01% 528

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Spark Investment Management's DNTH Position: Q2 2019 in Review

Spark Investment Management sold out of Dianthus Therapeutics (DNTH) in Q2 2019, closing a stake of 1,550 shares — an estimated $408K sold.

Spark Investment Management first reported a position in DNTH in Q4 2018 and held it in 2 quarters. The position peaked at $408K in Q1 2019. 70 funds tracked by Wall St. Rank hold DNTH as of Q2 2019.

  • Spark Investment Management reported no remaining Dianthus Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 1,550 Dianthus Therapeutics shares in Q2 2019, an estimated $408K.
  • Spark Investment Management first reported a position in Dianthus Therapeutics in Q4 2018 and held it in 2 quarters.
  • Spark Investment Management's Dianthus Therapeutics position peaked at $408K in Q1 2019.
  • 70 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.